Fundraising Fox

Artio Medical

Prairie Village, US · Founded 2013 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

Artio Medical was founded in 2013 by Frank Nicholas Franano and F. Nicholas Franano.

FN
Frank Nicholas FrananoCo-founder
FN
F. Nicholas FrananoManager
MS
Maria SainzNamed on SEC filing
JM
James M. SchultzNamed on SEC filing
NH
Nathaniel HagedornNamed on SEC filing
JA
John AyresNamed on SEC filing
AS
Abhinav ShuklaNamed on SEC filing

Board

WP
William P. WhitakerManager

Investors · 1

Serra VenturesreportedChampaign · $5M

Reported raises · per SEC filings

Form D private placements

$62.6M disclosed across 7 of 9 rounds · 2014–2022

▶$5.1MraisedDec 2022 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nathaniel HagedornDirector
  • James M. SchultzDirector
  • Sean MorrisExecutive Officer, Director
  • Frank Nicholas FrananoExecutive Officer, Director
Offering amount
$10M
Amount sold
$5.1M
Minimum investment
$50K
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$16.3MraisedJul 2022 · 90 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph McConnellExecutive Officer
  • James M. SchultzDirector
  • Nathaniel HagedornDirector
  • Frank Nicholas FrananoExecutive Officer, Director
  • Abhinav ShuklaDirector
  • John AyresExecutive Officer
Offering amount
$36M
Amount sold
$16.3M
Minimum investment
$50K
First sale
Feb 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$11.4MraisedFeb 2022 · 58 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Joseph McConnellExecutive Officer
  • John AyresExecutive Officer
  • Frank Nicholas FrananoExecutive Officer, Director
  • James M. SchultzDirector
  • Nathaniel HagedornDirector
  • Abhinav ShuklaDirector
  • Maria SainzDirector
Offering amount
$12M
Amount sold
$11.4M
Minimum investment
$25K
First sale
Aug 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7MraisedAug 2021 · 56 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Maria SainzDirector
  • James M. SchultzDirector
  • Nathaniel HagedornDirector
  • John AyresExecutive Officer
  • Abhinav ShuklaDirector
  • Frank Nicholas FrananoExecutive Officer, Director
Offering amount
$7M
Amount sold
$7M
Minimum investment
$10K
First sale
Feb 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedFeb 2021 · 68 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James M. SchultzDirector
  • Frank Nicholas FrananoExecutive Officer, Director
  • Maria SainzDirector
  • Jenny MartinExecutive Officer
  • Nathaniel HagedornDirector
  • Jeff WeinrichDirector
  • John AyresExecutive Officer
Offering amount
$5M
Amount sold
$5M
Minimum investment
$10K
First sale
Aug 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$402.2KraisedOct 2020 · 8 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nathaniel HagedornDirector
  • Jenny MartinExecutive Officer
  • Jeff WeinrichDirector
  • Frank Nicholas FrananoExecutive Officer, Director
  • James M. SchultzDirector
  • Maria SainzDirector
Amount sold
$402.2K
Minimum investment
$10K
First sale
May 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶Undisclosed amountofferedOct 2020 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Nathaniel HagedornDirector
  • Frank Nicholas FrananoExecutive Officer, Director
  • Jenny MartinExecutive Officer
  • James M. SchultzDirector
  • Maria SainzDirector
  • Jeff WeinrichDirector
Minimum investment
$10K
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$17.5MraisedOct 2020 · 132 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jenny MartinExecutive Officer
  • Frank Nicholas FrananoExecutive Officer, Director
  • Nathaniel HagedornDirector
  • Jeff WeinrichDirector
  • Maria SainzDirector
  • James M. SchultzDirector
Offering amount
$17.5M
Amount sold
$17.5M
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 3 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2018$1.5M
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$220.8K
National Institutes of Health (NIH)National Institutes of HealthPhase I2015$224.6K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

Who founded Artio Medical?
Artio Medical was founded by Frank Nicholas Franano, F. Nicholas Franano in 2013.
Who are Artio Medical's investors?
Artio Medical's investors include Serra Ventures.
How much funding has Artio Medical raised?
Artio Medical has disclosed $62.6M raised across 7 of its 9 known rounds.
Where is Artio Medical headquartered?
Artio Medical is headquartered in Prairie Village, US.